Showing results (1611-1620 of 2,507) with videos related to
Sort By:
Pageof 251
Journal of Diabetes Investigation|May 21, 2014
Clinical heterogeneity of adult Japanese diabetes depending on titers of glutamic acid decarboxylase autoantibodiesTomohisa Aoyama, Hiroki Ikeda, Yoshiyuki Hamamoto, et al.Journal of Diabetes Investigation|May 21, 2014
Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysisShinji Kume, Takashi Uzu, Chieko Takagi, et al.Journal of Diabetes Investigation|May 21, 2014
Chymase inhibition prevents myocardial fibrosis through the attenuation of NOX4-associated oxidative stress in diabetic hamstersYasutaka Maeda, Toyoshi Inoguchi, Ryoko Takei, et al.Journal of Diabetes Investigation|May 21, 2014
Optimal cut-off point for homeostasis model assessment of insulin resistance to discriminate metabolic syndrome in non-diabetic Japanese subjectsChizumi Yamada, Kengo Moriyama, Eiko TakahashiJournal of Diabetes Investigation|May 21, 2014
Ingestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon-like peptide-1 secretionEriko Sakamoto, Yusuke Seino, Ayako Fukami, et al.Journal of Diabetes Investigation|May 21, 2014
Localization of hepatocyte nuclear factor-4α in the nucleolus and nucleus is regulated by its C-terminusMakiko Ogata, Takeo Awaji, Naoko Iwasaki, et al.Journal of Diabetes Investigation|May 21, 2014
Increased plasma levels of retinol-binding protein 4 with visceral obesity is associated with cardiovascular risk factorsJong Chul Won, Cheol-Young Park, Sang Woo Oh, et al.Journal of Diabetes Investigation|May 21, 2014
Challenges in achieving optimal glycemic control in type 2 diabetes patients with declining renal function: The Southeast Asia perspectiveFrancis Cc Chow, Siew-Pheng Chan, Chii-Min Hwu, et al.Journal of Diabetes Investigation|May 21, 2014
Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patientsAkira Kubota, Hajime Maeda, Akira Kanamori, et al.Journal of Diabetes Investigation|May 21, 2014
Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension studyYutaka Seino, Shinzo Hiroi, Masashi Hirayama, et al.Pageof 251